Abstract
Salusin-α is a new bioactive peptide with mild hypotensive and bradycardic effects. Our recent study showed that salusin-α suppresses foam cell formation in human monocyte-derived macrophages by down-regulating acyl-CoA:cholesterol acyltransferase-1, contributing to its anti-atherosclerotic effect. To clarify the clinical implications of salusin-α in hypertension and its complications, we examined the relationship between serum salusin-α levels and carotid atherosclerosis in hypertensive patients. The intima-media thickness (IMT) and plaque score in the carotid artery, blood pressure, serum levels of salusin-α, and atherosclerotic parameters were determined in 70 patients with essential hypertension and in 20 normotensive controls. There were no significant differences in age, gender, body mass index, fasting plasma glucose level, or serum levels of high-sensitive C-reactive protein, high- or low-density lipoprotein (LDL) cholesterol, small dense LDL, triglycerides, lipoprotein(a), or insulin between the two groups. Serum salusin-α levels were significantly lower in hypertensive patients than in normotensive controls. The plasma urotensin-II level, maximal IMT, plaque score, systolic and diastolic blood pressure, and homeostasis model assessment for insulin resistance (HOMA-IR) were significantly greater in hypertensive patients than in normotensive controls. In all subjects, maximal IMT was significantly correlated with age, systolic blood pressure, LDL cholesterol, urotensin-II, salusin-α, and HOMA-IR. Forward stepwise multiple linear regression analysis revealed that salusin-α levels had a significantly independent and negative association with maximal IMT. Serum salusin-α levels were significantly lower in accordance with the severity of plaque score. Our results suggest that the decrease in serum salusin-α, an anti-atherogenic peptide, may be associated with carotid atherosclerosis in hypertensive patients.
Similar content being viewed by others
Article PDF
References
Shichiri M, Ishimaru S, Ota T, Nishikawa T, Isogai T, Hirata Y : Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 2003; 9: 1166–1172.
Sato K, Koyama T, Tateno T, Hirata Y, Shichiri M : Presence of immunoreactive salusin-α in human serum and urine. Peptides 2006; 27: 2561–2566.
Izumiyama H, Tanaka H, Egi K, Sunamori M, Hirata Y, Shichiri M : Synthetic salusins as cardiac depressors in rat. Hypertension 2005; 45: 419–425.
Watanabe T, Koba S, Shichiri M, et al: Impact of salusin-α and -β on human macrophage foam cell formation and coronary atherosclerosis. Circulation 2008; 117: 638–648.
Yu F, Zhao J, Yang J, et al: Salusins promote cardiomyocyte growth but does not affect cardiac function in rats. Regul Pept 2004; 122: 191–197.
Hong-Xiao Y, Li L, Yan-Xia P, et al: Salusins protect neonatal rat cardiomyocytes from serum deprivation-induced cell death through upregulation of GRP78. J Cardiovasc Pharmacol 2006; 48: 41–46.
Watanabe T, Kanome T, Miyazaki A, Katagiri T : Human urotensin II linking hypertension and coronary artery disease. Hypertens Res 2006; 29: 375–387.
Japanese Society of Hypertension : Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res 2006; 29: S1–S105.
Suguro T, Watanabe T, Ban Y, et al: Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension. Am J Hypertens 2007; 20: 211–217.
Hirano T, Ito Y, Koba S, et al: Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol 2004; 24: 558–563.
Suzuki N, Shichiri M, Akashi T, et al: Systemic distribution of salusin expression in the rat. Hypertens Res 2007; 30: 1255–1262.
Pennings M, Meurs I, Ye D, et al: Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett 2006; 580: 5588–5596.
Reid JA, Wolsley C, Lau LL, et al: The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol. Eur J Vasc Endovasc Surg 2005; 30: 464–468.
Kooistra T, Verschuren L, de Vries-van der Weij J, et al: Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol. Arterioscler Thromb Vasc Biol 2006; 26: 2322–2330.
Mortsell D, Malmqvist K, Held C, Kahan T : Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study. J Intern Med 2007; 261: 472–479.
Uchiyama-Tanaka Y, Mori Y, Kishimoto N, et al: Comparison of the effects of quinapril and losartan on carotid artery intima-media thickness in patients with mild-to-moderate arterial hypertension. Kidney Blood Press Res 2005; 28: 111–116.
Shichiri M : Reply to ‘Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities.’ Nat Med 2007; 13: 661–662.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Watanabe, T., Suguro, T., Sato, K. et al. Serum Salusin-α Levels Are Decreased and Correlated Negatively with Carotid Atherosclerosis in Essential Hypertensive Patients. Hypertens Res 31, 463–468 (2008). https://doi.org/10.1291/hypres.31.463
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.463
Keywords
This article is cited by
-
Serum salusin-α and -β levels in patients with parkinson’s disease
Neurological Sciences (2024)
-
The role of serum salusin alpha and beta levels and atherosclerotic risk factors in idiopathic sudden hearing loss pathogenesis
European Archives of Oto-Rhino-Laryngology (2022)
-
Evaluation of salusin-α and salusin-β levels in patients with type 2 diabetes mellitus and determination of the impact of severity of hyperglycemia on salusin levels
Irish Journal of Medical Science (1971 -) (2021)
-
Salusin β Within the Nucleus Tractus Solitarii Suppresses Blood Pressure Via Inhibiting the Activities of Presympathetic Neurons in the Rostral Ventrolateral Medulla in Spontaneously Hypertensive Rats
Cardiovascular Toxicology (2016)
-
Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?
Pediatric Nephrology (2015)